Genomics in Cancer Care Market to Grow with a CAGR of 16.91% through 2030
Advancements in
next-generation sequencing (NGS) technology and increasing adoption of
precision medicine, is expected to drive the Global Genomics in Cancer Care
Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “Genomics in Cancer Care Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2030F”,
the Global Genomics in Cancer Care Market stood at USD 15.73 Billion in
2024 and is expected to reach USD 40.22 Billion by 2030 with a CAGR of 16.91% during
the forecast period. The Global Genomics in Cancer Care Market is undergoing
rapid transformation driven by continuous innovation in molecular diagnostics
and targeted therapies. The increasing emphasis on tumor profiling and genetic
sequencing has enabled oncologists to develop personalized treatment plans,
improving patient survival rates. Research advancements in circulating tumor
DNA (ctDNA) analysis and single-cell sequencing are revolutionizing early
detection and treatment monitoring. The expanding role of big data and cloud
computing in genomic research is streamlining data storage, analysis, and
sharing, accelerating the pace of discoveries in oncology care.
Key growth
drivers include the surge in clinical trials exploring gene-based therapies,
rising demand for pharmacogenomics, and the increasing role of public-private
partnerships in cancer genomics research. The expansion of multi-cancer early
detection (MCED) tests is broadening the scope of genomic applications in
oncology. Improvements in sequencing accuracy and turnaround time are making
genomic testing more accessible to healthcare providers. The growing
availability of direct-to-consumer genetic tests is fostering patient awareness
and encouraging proactive cancer risk assessment. Collaborations between
biotech firms and healthcare institutions are driving the commercialization of
advanced genomic solutions, contributing to the market's upward trajectory.
The market
presents several growth opportunities, including the rise of CRISPR-based gene
editing in cancer therapeutics and the exploration of novel genomic biomarkers
for rare cancers. The expansion of liquid biopsy applications beyond detection
to treatment response prediction is unlocking new commercial prospects.
Advancements in nanopore sequencing and single-molecule analysis are expected
to further refine genomic insights, improving precision oncology approaches.
The increasing integration of genomics with immunotherapy is paving the way for
highly personalized cancer treatments. Strategic investments in AI-powered
genomic analytics and cloud-based bioinformatics platforms will drive the next
phase of innovation, solidifying genomics as a cornerstone of cancer care.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "Global Genomics in Cancer Care Market”
The Global Genomics
in Cancer Care Market is segmented into product, technology, application, end
user, regional distribution, and company.
Based on the Application,
Personalized Medicine emerged
as the fastest growing segment in the Global Genomics in Cancer Care Market during
the forecast period. This is due to the increasing shift toward targeted
therapies and precision oncology. Advances in genomic technologies have enabled
the identification of specific genetic mutations and biomarkers that drive
cancer progression, allowing for the development of tailored treatment
approaches. The growing adoption of next-generation sequencing (NGS) and
companion diagnostics has revolutionized cancer care by enabling oncologists to
prescribe therapies based on an individual’s genetic profile, improving
treatment efficacy and minimizing adverse effects. The rising prevalence of
cancer and the demand for more effective and less toxic treatment options have
further accelerated the adoption of personalized medicine. Pharmaceutical
companies are investing heavily in biomarker-driven drug development, leading
to a surge in regulatory approvals for targeted therapies. The integration of
artificial intelligence (AI) and bioinformatics in genomic analysis is
enhancing precision medicine by streamlining data interpretation and
facilitating real-time decision-making in oncology.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
Genomics in Cancer Care Market during
the forecast period. This is due to increasing investments in precision
medicine, expanding healthcare infrastructure, and rising cancer prevalence.
Governments across countries such as China, Japan, and India are actively
promoting genomic research and implementing national initiatives to integrate
genomics into oncology care. Significant funding from public and private
sectors for next-generation sequencing (NGS) technologies, biomarker discovery,
and personalized medicine programs is accelerating market growth. The region’s
large patient population and improving accessibility to advanced genomic
testing are further driving demand for genomics-based cancer diagnostics and
treatment. Rapid advancements in biotechnology, coupled with a surge in
pharmaceutical and biotech collaborations, are facilitating the development of
targeted therapies. The increasing adoption of liquid biopsy and companion
diagnostics, particularly in countries with strong regulatory support like
Japan and South Korea, is enhancing early cancer detection and treatment
monitoring. Additionally, declining sequencing costs and the expansion of local
genomic service providers are making precision oncology more affordable and
widely available. The growing presence of international genomics companies and
strategic partnerships with regional healthcare institutions are strengthening
Asia-Pacific’s position as a key driver of growth in the global genomics in
cancer care market.
Major companies
operating in Global Genomics in Cancer Care Market are:
- Illumina Inc
- Agilent Technologies, Inc.
- Roche Diagnostics
- Cancer Genetics, Inc.
- Bio-Rad Laboratories Inc
- Sigma-Aldrich Corp
- QIAGEN NV
- GE Healthcare Inc
- Life Technologies Corp
- Quest Diagnostics Inc
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The Global
Genomics in Cancer Care Market is expanding due to the growing adoption of
multi-omics approaches, including genomics, transcriptomics, and proteomics,
which are revolutionizing cancer diagnostics and treatment. By integrating data
from multiple molecular layers, researchers and clinicians can gain deeper
insights into tumor biology, leading to more precise patient stratification and
targeted therapy development. This comprehensive approach enhances the accuracy
of biomarker identification, improves treatment response predictions, and
accelerates drug discovery. The increasing use of artificial intelligence and
bioinformatics in multi-omics data analysis is further driving advancements in
precision oncology.,” said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“Genomics in Cancer Care
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
Segmented By Product (Instruments, Consumables, Services), By Technology
(Genome Sequencing, PCR, Microarray, Nucleic Acid Extraction and Purification,
Others), By Application (Diagnostics, Personalized Medicine, Drug Discovery
& Development, Research), By End User (Hospitals, Research Institutes &
Academic Institutes, Others), By Region and Competition, 2020-2030F”,
has evaluated the future growth potential of Global Genomics in Cancer Care
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Genomics in Cancer
Care Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com